Physician profile
Joan E Fox
NPI 1649789850
$2,742.71
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,664 · 2022: $979 · 2023: $76.32 · 2024: $22.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $505.69 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $313.10 | 2021-2022 | |
| Neos Therapeutics, LP | $294.06 | 2021-2022 | |
| Abbvie INC. | $290.52 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $280.39 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $249.39 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $229.34 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $131.02 | 2021-2022 | |
| Corium, LLC | $115.13 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $75.13 | 2021-2022 | |
| Bausch Health US, LLC | $65.21 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $41.65 | 2023 | |
| Acacia Pharma INC | $39.41 | 2022 | |
| Alkermes, INC. | $39.34 | 2021-2022 | |
| Almatica Pharma LLC | $33.10 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.98 | 2024 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $17.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.